genetic disorder
Nov 01, 2024
5 Promising Pompe Disease Drugs in Early-stage Development
Imagine a disease that stealthily incapacitates the heart, liver, and skeletal muscles—slowly breaking them down due to the absence of a crucial protein. That's the story of Pompe disease, also known as glycogen storage disease type II (GSDII). Caused by a gene mutation that blocks the body’s ability to break down ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
